The first Aerie Pharmaceuticals trade was made in Q2 2015.
Since then Ken Griffin bought shares 30 more times and sold shares on 40 occasions. The investor sold all their shares in Q4 2022 and doesn't own any shares in Aerie Pharmaceuticals anymore.
Avg closing price
Price range
Sold -229 Thousand shares
Q4 2022
Avg closing price
$15.21
Price range
$15.10
-
$15.25
Increased shares by 148.5% (+137 Thousand shares)
Q3 2022
Avg closing price
$11.62
Price range
$6.37
-
$15.23
Sold 0.8% shares (-775 shares)
Q2 2022
Avg closing price
$7.05
Price range
$4.95
-
$9.16
Increased shares by 163.6% (+57.6 Thousand shares)
Q1 2022
Avg closing price
$7.71
Price range
$5.64
-
$9.80
Sold 94.6% shares (-620 Thousand shares)
Q4 2021
Avg closing price
$10.46
Price range
$7.02
-
$13.33
Increased shares by 979.4% (+595 Thousand shares)
Q3 2021
Avg closing price
$14.62
Price range
$11.32
-
$16.63
Sold 30.9% shares (-27.1 Thousand shares)
Q2 2021
Avg closing price
$17.15
Price range
$15.16
-
$18.97
Sold 89.7% shares (-763 Thousand shares)
Q1 2021
Avg closing price
$17.27
Price range
$13.12
-
$20.90
Sold 50.1% shares (-856 Thousand shares)
Q3 2020
Avg closing price
$12.18
Price range
$10.46
-
$14.46
Increased shares by 370.8% (+1.34 Million shares)
Q2 2020
Avg closing price
$14.79
Price range
$12.00
-
$16.13
Sold 56.4% shares (-470 Thousand shares)
Q1 2020
Avg closing price
$18.97
Price range
$11.84
-
$25.52
Increased shares by 185.7% (+541 Thousand shares)
Q4 2019
Avg closing price
$20.71
Price range
$17.72
-
$25.10
Increased shares by 130.3% (+165 Thousand shares)
Q3 2019
Avg closing price
$22.91
Price range
$18.41
-
$28.00
Sold 65.0% shares (-235 Thousand shares)
Q2 2019
Avg closing price
$38.53
Price range
$28.97
-
$48.21
Sold 76.5% shares (-1.18 Million shares)
Q1 2019
Avg closing price
$44.01
Price range
$36.32
-
$49.25
Increased shares by 10.6% (+148 Thousand shares)
Q4 2018
Avg closing price
$46.91
Price range
$33.00
-
$60.04
Increased shares by 15174.9% (+1.38 Million shares)
Q3 2018